Back to results
US 2026/0150836 A1Published application
Deuterium-labelled cannalactone synthesis and use for the dosage of cannalactone in all tissues or exudates of living plants or organisms
OwnerFrançois Didier BOYER, Jean Bernard POUVREAU +3inventors
InventorsFrançois Didier BOYER, Jean Bernard POUVREAU, Alexandre MACIUK, Suzanne DAIGNAN FORNIER DE LACHAUX, Fabienne MATHIS
Life of this patent
Estimating the term…
Abstract
The present invention relates to the chemical synthesis of cannalactone, an adaptation of this synthesis leading to deuterium labeling of cannalactone, as well as the use of deuterium-labeled cannalactone to perform the dosage of natural cannalactone of the exudates or tissues of the hemp plant.
Claims12
A deuterium-labeled cannalactone, wherein the deuterium-labeled cannalactone corresponds to the general Formula (1):
- wherein:
- R1 denotes a hydrogen atom H or a deuterium atom D, —R2 denotes the methyl radical CH3 or the trisubstituted deuterated methyl radical CD3,
- at least one of R1 and R2 being deuterated.
Method A method of synthesizing cannalactone, of general Formula (5)
- the method comprising:
- a reaction A) of coupling commercial β-cyclocitral with unbromofuran C4 of Formula (6)
- to obtain an alcohol B20 of Formula (7)
- a step B) of reducing the alcohol B20 of Formula (7), to obtain a mixture of diastereoisomers of the allyl alcohol, followed by a step of separating said diastereoisomers to retain the diastereoisomer (4R*, 6R*)-B21 of Formula (8)
- a step C) of selectively epoxidizing the compound (4R*, 6R*)-B21 of Formula (8) to obtain the epoxy 4R*, 6R*)-cis-B22 of Formula (9)
- a radical reaction D) of reduction and isomerization of the epoxide (4R*, 6R*)-cis-B22 of Formula (9), to obtain the tertiary alcohol (4R*, 8R*)-B1 of Formula (10)
- a step E) of protecting the tertiary alcohol (4R*, 8R*)-B1 of Formula (10), to obtain the protected alcohol (4R*, 8R*)-B23 of Formula (11)
- a step F) comprising formylation F1) of the compound (4R*, 8R*)-B23 of Formula (11) using alkyl formate corresponding to Formula (12)
- then O-alkylation F2) of the aldehyde thus formed using compound D4 of Formula (13)
- leading to obtaining the diastereoisomer mixture (4R*,6R*) B24 of Formula (14)
- a step G) of deprotecting and separating the diastereoisomers of Formula (14), leading to the isolation of the cannalactone of Formula (5).
8 more elements
Dependencies are inferred from the claim text.